Blackstone Inc.

🇺🇸New York Stock Exchange

Articles

42
Show Summary
Show Bulletpoints
Detailed View
Slightly Bullish +25

Digital Realty Prices Secondary Offering of Common Stock by Blackstone

📈 Digital Realty priced 12.3M shares at $185 by Blackstone affiliates.

💰 Deal contingent on closing Blackstone's joint venture acquisition interests.

📅 Offering expected to close July 1, 2026, subject to conditions.

🏦 Morgan Stanley served as sole underwriter for the public offering.

🔄 Shares are non-voting but convert to common stock upon transfer.

📈 Digital Realty priced a secondary offering of 12,310,249 shares by Blackstone affiliates at $185.00 per share.

💰 The transaction is contingent on the closing of Blackstone's acquisition of interests in the Digital Carver Dulles 9 and Digital Carver Brickyard joint ventures.

📅 The offering is expected to close on July 1, 2026, subject to standard closing conditions.

🏦 Morgan Stanley acted as the sole underwriter for this public offering pursuant to an effective shelf registration statement.

🔄 Shares issued to Blackstone are non-voting but will automatically convert into one share of Digital Realty's common stock upon transfer.

💸 Digital Realty is not selling any shares in this offering and will receive no proceeds from the sale.

🌍 The company operates a global footprint of 300+ facilities across 55+ metros in 30+ countries supporting AI and cloud solutions.

Bullish Signals
  • Acquiring Blackstone's Dulles 9 and Brickyard interests expands portfolio.
Risk Factors
  • Digital Realty receives no proceeds from the secondary offering.
  • Offering depends on Blackstone Acquisition closing; delays risk cancellation.
Bullish Signals
  • Digital Realty is acquiring Blackstone's interests in two significant joint ventures (Dulles 9 and Brickyard), which likely expands its data center portfolio and strategic positioning.
  • The company continues to grow its global footprint with over 300 facilities supporting high-demand sectors like AI and cloud computing.
Risk Factors
  • Digital Realty will not receive any proceeds from the secondary offering, meaning this capital raise benefits Blackstone rather than providing direct cash infusion to Digital Realty.
  • The transaction is conditioned on the closing of the Blackstone Acquisition; if that deal fails or is delayed, the offering may not proceed as planned.
Somewhat Bullish +35

Blackstone Inc. (NYSE:BX) Given Average Rating of "Moderate Buy" by ...

📊 Analysts rate Blackstone a 'Moderate Buy' with a $150.86 price target.

💰 Q1 EPS beat estimates at $1.36, while revenue rose 10% YoY.

🏦 Net margin hit 20.67% and ROE reached 22.86% this quarter.

💸 Quarterly dividend is $1.16 per share with a 3.9% yield.

📉 Major shareholder sold shares while Treasury Holdings bought nearly $190M.

📊 Blackstone Inc. (NYSE:BX) holds an average analyst rating of 'Moderate Buy' with a consensus twelve-month price target of $150.86.

📈 The stock received upgrades from Zacks Research to 'hold' and Royal Bank of Canada issued an 'outperform' rating recently.

📉 Barclays lowered its price target to $124.00 with an 'equal weight' rating, while Morgan Stanley reduced its objective to $184.00.

💰 Blackstone reported Q1 EPS of $1.36, beating the consensus estimate of $1.34 by $0.02.

📉 Revenue for the quarter was $3.43 billion, slightly missing analyst expectations of $3.45 billion but up 10% year-over-year.

🏦 The company achieved a net margin of 20.67% and a return on equity of 22.86% during the reported period.

💸 Blackstone paid a quarterly dividend of $1.16 per share, yielding 3.9% annually to investors of record on May 4th.

📉 Major shareholder Bx Buzz Ml-1 Gp Llc sold 7.48 million shares for approximately $28.3 million in a single transaction.

📈 Treasury Holdings I purchased 9.49 million shares at an average price of $20.00, investing roughly $189.7 million.

🏛️ Institutional investors and hedge funds collectively own 70% of Blackstone's outstanding stock.

Bullish Signals
  • EPS beat: $1.36 vs $1.34 consensus.
  • Net margin 20.67% and ROE 22.86%.
  • Revenue grew 10.0% to $3.43 billion.
  • Dividend yield of 3.9% with $1.16 payout.
  • Treasury Holdings bought 9.5M shares at $20.
  • Zacks upgraded from 'strong sell' to 'hold'.
Risk Factors
  • Revenue of $3.43B missed expectations of $3.45B.
  • Major shareholder sold 7.48M shares for 99.74% drop.
  • Morgan Stanley cut target to $184 from $215.
  • Barclays lowered target to $124 with neutral rating.
Bullish Signals
  • Blackstone beat quarterly EPS expectations with a result of $1.36 versus the consensus of $1.34, demonstrating operational strength.
  • The company achieved a robust net margin of 20.67% and a return on equity of 22.86%, indicating efficient capital deployment.
  • Revenue grew by 10.0% year-over-year to reach $3.43 billion, showing continued business expansion despite missing top-line estimates.
  • The stock offers an attractive dividend yield of 3.9% with a recent quarterly payout of $1.16 per share.
  • Major shareholder Treasury Holdings I significantly increased its stake by purchasing nearly 9.5 million shares at $20.00 each, signaling strong insider confidence.
  • Zacks Research upgraded the stock from 'strong sell' to 'hold', reflecting a positive shift in analyst sentiment regarding the company's trajectory.
Risk Factors
  • Blackstone's quarterly revenue of $3.43 billion missed analyst expectations of $3.45 billion, indicating potential headwinds in top-line growth.
  • Major shareholder Bx Buzz Ml-1 Gp Llc drastically reduced its position by selling 7.48 million shares, representing a 99.74% decrease in ownership.
  • Morgan Stanley lowered its price objective from $215.00 to $184.00, suggesting some analysts see limited upside potential at current levels.
  • Barclays reduced its price target to $124.00 and assigned an 'equal weight' rating, reflecting a neutral-to-negative outlook on the stock's immediate prospects.
Somewhat Bullish +50

Blackstone (NYSE: BX) projects $500M+ in Q2 2026 realization revenue - Stock Titan

📅 Blackstone reports April-June 2026 revenue update covering partial period.

💰 Firm expects over $500M in realized performance and principal income.

🚀 Revenue driven almost entirely by investment exits and incentive fees.

⚠️ Estimate excludes fees, expenses, and activity after June 23, 2026.

📉 Full quarter results may differ materially from this partial estimate.

📅 Blackstone provides an intra-quarter revenue update covering the period from April 1, 2026, through June 23, 2026.

💰 The firm preliminarily expects to record total Realized Performance Revenues and Realized Principal Investment Income in excess of $500 million for the specified period.

🚀 This revenue estimate is almost entirely comprised of Realized Performance Revenues generated from investment exits and incentive fees.

⚠️ The announcement explicitly excludes fee income, operating expenses, and any realization activity occurring after June 23, 2026.

📉 Results for the full quarter ending June 30, 2026, may differ materially from this partial period estimate.

🏢 Blackstone manages over $1.3 trillion in assets under management across real estate, private equity, credit, and other global strategies.

📝 The filing is a Form 8-K disclosing forward-looking statements regarding preliminary revenue expectations under Regulation Fair Disclosure.

🔮 Additional gains or losses relating to Realized Performance Revenues may be realized for the full quarter beyond this estimate.

Bullish Signals
  • Realization-related revenue exceeds $500 million for partial Q2.
  • Manages over $1.3 trillion in assets under management.
Risk Factors
  • Estimate covers partial quarter; full Q2 results may vary.
  • Revenue estimates face risks causing material outcome differences.
Bullish Signals
  • Blackstone projects realization-related revenue exceeding $500 million for the partial Q2 period, indicating strong investment exit activity and successful incentive fee recognition.
  • The firm manages over $1.3 trillion in assets under management, demonstrating its scale and market position as a leading alternative asset manager.
Risk Factors
  • The $500 million estimate covers only a portion of the quarter (April 1 to June 23) and excludes fee income and expenses, meaning full Q2 results could be lower or higher than this figure.
  • Forward-looking statements regarding revenue estimates are subject to risks and uncertainties that could cause actual outcomes to differ materially from expectations.
Bullish +55

Evolve Private Wealth LLC Has $2.16 Million Holdings in Blackstone Inc. $BX - MarketBeat

📈 Q4 EPS beat estimates at $1.36 on $3.43B revenue growth.

💰 Evolve Private Wealth increased stake by 138% to 18,802 shares.

📉 Analysts lowered price targets; HSBC now rates stock 'hold'.

💵 Quarterly dividend of $1.16 carries high 118.67% payout ratio.

🏛️ Treasury Holdings I acquired nearly 9.5 million shares worth $189.7M.

📈 Blackstone reported Q4 EPS of $1.36, beating the consensus estimate of $1.34.

💰 Revenue grew 10% year-over-year to reach $3.43 billion for the quarter.

🏦 Evolve Private Wealth LLC increased its stake by 138% to hold 18,802 shares worth $2.16 million.

📉 HSBC lowered its price target from $164.00 to $131.00 with a 'hold' rating.

📉 Barclays reduced its target price from $126.00 to $124.00 with an 'equal weight' rating.

💵 The company paid a quarterly dividend of $1.16, yielding 3.8% annually.

⚠️ The dividend payout ratio is high at 118.67%, indicating potential sustainability concerns.

📊 Institutional ownership stands at 70%, with several wealth managers increasing stakes.

👤 Director Ruth Porat purchased 355 shares, increasing her total holdings by 0.86%.

🏛️ Treasury Holdings I acquired nearly 9.5 million shares worth approximately $189.7 million.

📈 The stock trades at a PE ratio of 31.50 with a market cap of $91.51 billion.

📉 The current share price is below the 200-day moving average of $130.08.

Bullish Signals
  • EPS beat at $1.36 vs expected $1.34.
  • Revenue grew 10% YoY to $3.43 billion.
  • Healthy ROE of 22.86% and net margin of 20.67%.
  • Institutional investors like Evolve Private Wealth increased holdings.
  • Deutsche Bank initiated with a 'buy' rating.
  • Evercore reissued 'outperform' with $150 price target.
  • Stock offers 3.8% annualized dividend yield.
Risk Factors
  • Dividend payout ratio elevated at 118.67%.
  • HSBC cut price target to $131.00.
  • Barkeley lowered target to $124.00.
  • Stock trades below 200-day moving average of $130.08.
Bullish Signals
  • Blackstone beat earnings per share expectations, reporting $1.36 versus the expected $1.34.
  • Revenue increased by 10% year-over-year to $3.43 billion, demonstrating solid top-line growth.
  • The company maintains a healthy return on equity of 22.86% and a net margin of 20.67%.
  • Multiple institutional investors, including Evolve Private Wealth LLC, significantly increased their holdings in the first quarter.
  • Deutsche Bank initiated coverage with a 'buy' rating, signaling confidence from new analysts.
  • Evercore reissued an 'outperform' rating with a $150.00 price target, supporting bullish sentiment.
  • The stock offers a 3.8% annualized dividend yield to shareholders.
Risk Factors
  • The dividend payout ratio is elevated at 118.67%, suggesting the company may be paying out more in dividends than it generates in earnings.
  • HSBC reduced its price target from $164.00 to $131.00, indicating a bearish shift in analyst expectations.
  • Barkeley lowered its price target from $126.00 to $124.00 and assigned an 'equal weight' rating.
  • The stock is currently trading below its 200-day moving average of $130.08, indicating potential short-term weakness.
Somewhat Bullish +35

APGE Stock Surges On Trial Win And $1.3B Blackstone Deal - StocksToTrade

📈 APGE stock surged 46.72% to near $132.61 on positive data.

💊 Mid-dose Zumilokibart showed 65.9% efficacy, beating Dupixent benchmarks.

💰 Blackstone Life Sciences provided up to $1.3B in non-dilutive capital.

📅 Phase 3 trials scheduled to commence in the second half of 2026.

💵 Company holds over $1B cash against only $4.9M debt.

📈 APGE stock surged 46.72% to trade near $132.61 driven by positive Phase 2 data and a major financing announcement.

💊 Zumilokibart mid-dose achieved 65.9% EASI-75 response in atopic dermatitis, showing better efficacy than Dupixent on key benchmarks.

💰 Blackstone Life Sciences provided up to $1.3B in non-dilutive capital ($800M royalty + $500M debt) to fund Phase 3 trials.

📅 Phase 3 registrational trials are scheduled to commence in the second half of 2026.

🏦 Wedbush raised its price target to $135 with an Outperform rating, citing superior historical efficacy potential.

⚖️ Analyst targets are mixed, ranging from Goldman Sachs' $89 Neutral to RBC's $97 speculative risk rating.

💵 Company holds over $1B in cash and short-term investments against only $4.9M in debt as of Q1 2026.

📉 Q1 2026 financials show a net loss of approximately $74M with operating cash flow of -$55.6M.

👥 Dermatologist surveys support a potential $2.5B U.S. revenue view for atopic dermatitis indications.

⚠️ RBC notes that the current share price may already discount much of the core atopic dermatitis story.

🔬 Goldman Sachs downgraded to Neutral after seeing no added efficacy from higher doses versus the mid-dose.

📉 Truist maintains an $81 target and Hold rating, arguing Part B results landed below high expectations.

Bullish Signals
  • Mid-dose zumilokibart hit 65.9% EASI-75 with clean safety.
  • $1.3B non-dilutive financing provides runway through Phase 3.
  • Wedbush raised target to $135 citing better efficacy than Dupixent.
  • Robust balance sheet holds over $1B cash against minimal debt.
  • Dermatologist survey supports $2.5B U.S. atopic dermatitis revenue view.
Risk Factors
  • RBC survey suggests current price discounts core atopic dermatitis story.
  • Weaker uptake in biologic-naive patients per RBC dermatologist survey.
  • Goldman downgraded to Neutral citing no added efficacy from higher dose.
  • Trist argues Part B results missed high expectations, Hold rating $81 target.
  • Q1 2026 net loss of $74M and operating cash flow of -$55.6M.
Bullish Signals
  • Strong Phase 2 APEX Part B data showed the mid-dose of zumilokibart hitting 65.9% EASI-75 with clean safety.
  • Up to $1.3B in non-dilutive financing from Blackstone provides runway through Phase 3 and commercialization.
  • Wedbush raised its price target to $135, citing better historical efficacy than current heavyweights like Dupixent.
  • Company balance sheet is robust with over $1B in cash and short-term investments against minimal debt.
  • Dermatologist survey supports a $2.5B U.S. atopic dermatitis revenue view driven by switching from existing biologics.
Risk Factors
  • RBC analyst survey signals that APGE's current share price already discounts much of the core atopic dermatitis story.
  • Uptake in biologic-naive patients looked weaker according to RBC's dermatologist survey.
  • Goldman Sachs downgraded to Neutral after seeing no added efficacy from a higher dose versus the mid-dose.
  • Truist argues that Part B results landed below high expectations, maintaining a Hold rating with an $81 target.
  • Q1 2026 financials show a net loss of about $74M and operating cash flow of roughly -$55.6M.
Slightly Bullish +25

Blackstone (BX) Stock Could Be 23.7% Undervalued After Credit Launch And Real Estate Hire - simplywall.st

🏢 Blackstone hires Carey Roberts as Senior Managing Director for real estate.

💰 Firm manages $177 billion in dry powder for opportunistic investments.

📈 Shares rose 4.4% in 30 days but fell 22.05% year to date.

🤝 Strategic alliance formed with Wellington and Vanguard for public-private solutions.

⚠️ Risks include fundraising setbacks and redemption pressure in the BCRED fund.

🏢 Blackstone expands its private credit platform with SablePointe Credit Strategies and hires Carey S. Roberts as Senior Managing Director for real estate.

💰 The firm manages $177 billion in dry powder available for opportunistic investments in undervalued assets.

📈 Share price has risen 4.4% over the past 30 days and 12.1% over 90 days, though it is down 22.05% year to date.

🤝 Blackstone forms a strategic alliance with Wellington and Vanguard to develop integrated public-private investment solutions.

💵 Revenue across multiple investing segments totals US$14.4 billion, driven largely by private markets.

📉 Simply Wall St's DCF model estimates a fair value of $113.42, implying the current price may be overvalued relative to future cash flows.

🎯 The 'Most Popular Narrative' suggests a fair value of $162.26, indicating a potential 23.7% undervaluation based on growth assumptions.

⚠️ Risks include potential setbacks in private wealth fundraising and prolonged redemption pressure in the BCRED fund.

Bullish Signals
  • Expanding into high-growth private credit and real estate.
  • Holds $177 billion in dry powder for future growth.
  • Alliance with Wellington and Vanguard expands revenue channels.
  • Stock gained 4.4% last month and 12.1% last quarter.
  • 54.64% total shareholder return over the past three years.
Risk Factors
  • Stock down 22.05% year to date.
  • DCF fair value $113.42 suggests overvaluation.
  • Private wealth fundraising setbacks risk fee revenue.
  • BCRED redemption pressure impacts cash flows.
Bullish Signals
  • Blackstone is strategically expanding into high-growth areas like private credit and real estate, which are already major revenue contributors.
  • The company holds $177 billion in dry powder, positioning it to capitalize on market dislocations and deploy capital for future earnings growth.
  • A strategic alliance with Wellington and Vanguard aims to tap into the private wealth market, potentially expanding revenue channels.
  • Recent stock performance shows resilience with a 4.4% gain over the last month and a 12.1% gain over the last quarter.
  • Long-term investor sentiment remains strong, evidenced by a 54.64% total shareholder return over the past three years.
Risk Factors
  • The stock is down 22.05% year to date, indicating significant short-term pressure despite longer-term gains.
  • A discounted cash flow model estimates a fair value of $113.42, suggesting the current market price may be overvalued relative to intrinsic worth.
  • Potential setbacks in private wealth fundraising could weigh on fee revenue and challenge the undervaluation thesis.
  • Prolonged redemption pressure in the BCRED fund could negatively impact cash flows and overall financial stability.
Bullish +62

Arrow Capital Management LLC Purchases New Holdings in Blackstone Inc ...

📈 Arrow Capital acquired 79,971 shares valued at $12.3 million.

📉 Major shareholder sold 7.48 million shares for $28.3 million.

💰 Director Ruth Porat increased her direct ownership stake.

📊 Q4 earnings beat estimates with revenue up 10% to $3.43 billion.

💵 Quarterly dividend of $1.16 per share offers a 3.7% yield.

📈 Arrow Capital Management LLC acquired 79,971 shares of Blackstone Inc., valuing the new stake at approximately $12.3 million.

📉 Major shareholder Bx Buzz Ml-1 Gp Llc sold 7.48 million shares on June 16th for a total value of $28.3 million.

💰 Director Ruth Porat purchased 355 shares at an average price of $123.04, increasing her direct ownership stake.

📊 Blackstone reported Q4 earnings of $1.36 EPS, beating the consensus estimate of $1.34 by $0.02.

📈 Revenue for the quarter reached $3.43 billion, representing a 10% increase compared to the same period last year.

💵 The company paid a quarterly dividend of $1.16 per share on May 11th with an annualized yield of 3.7%.

📉 Institutional investors and hedge funds collectively own 70% of the company's outstanding stock.

📊 Blackstone trades at a P/E ratio of 31.66 with a market capitalization of $91.95 billion.

📉 The stock opened at $123.78, trading below its 200-day moving average of $130.40.

🔮 Equities analysts forecast full-year earnings of $5.9 per share for Blackstone Inc.

Bullish Signals
  • EPS beat at $1.36 vs $1.34 estimate.
  • Revenue up 10% YoY to $3.43 billion.
  • Arrow Capital made it fourth-largest holding.
  • Insiders bought nearly $190 million recently.
  • Dividend yield is 3.7% with 20.67% net margin.
Risk Factors
  • Major shareholder sold over $28 million in shares.
  • Stock trades below 200-day moving average of $130.40.
  • Revenue of $3.43 billion missed analyst estimates.
Bullish Signals
  • Blackstone beat quarterly earnings expectations with EPS of $1.36 versus the consensus estimate of $1.34.
  • The company achieved a 10% year-over-year revenue increase, posting $3.43 billion in quarterly revenue.
  • Strong institutional interest is evident as Arrow Capital Management made Blackstone its fourth-largest holding.
  • Corporate insiders have been net buyers over the last ninety days, purchasing nearly $190 million worth of stock.
  • The firm offers a solid dividend yield of 3.7% with a payout ratio of 118.67%.
  • Blackstone maintains healthy profitability metrics including a 20.67% net margin and 22.86% return on equity.
Risk Factors
  • Major shareholder Bx Buzz Ml-1 Gp Llc reduced its position by 99.74%, selling over $28 million in shares.
  • The stock is currently trading below its 200-day moving average of $130.40, indicating potential short-term weakness.
  • Revenue of $3.43 billion slightly missed analyst estimates of $3.45 billion for the quarter.
Slightly Bearish -20

UBS (AMUB) issues autocallable notes linked to Blackstone, $9.37–$9.62 value - Stock Titan

📅 Trade June 15, 2026; Maturity June 20, 2028.

💰 Value $9.37–$9.62 per $10 note; Min purchase $1,000.

🔒 Linked to Blackstone Inc. common stock performance.

⚡ Auto-call if price hits initial level on observation dates.

📉 Principal repayment contingent on final level vs 70% threshold.

📅 Trade Date: June 15, 2026; Settlement: June 17, 2026; Maturity: June 20, 2028.

💰 Estimated Initial Value: $9.37–$9.62 per $10 note (minimum purchase $1,000).

📈 Underlying Asset: Common stock of Blackstone Inc.

🔒 Structure: Trigger Autocallable Contingent Yield Notes linked to equity performance.

💵 Coupon Feature: Periodic contingent coupons payable only if closing level meets the coupon barrier.

⚡ Auto-Call Feature: Early redemption occurs if closing level equals or exceeds initial level on an observation date.

📉 Downside Risk: If not called, principal repayment at maturity is contingent on final level vs. downside threshold (70%).

⚠️ Credit Risk: All payments are unsecured obligations of UBS AG and subject to issuer creditworthiness.

🏦 Issuer: UBS AG; Product Supplement dated February 6, 2025.

Bullish Signals
  • Potential periodic contingent coupons if price stays above barrier.
  • Automatic early redemption of principal plus accrued coupons on performance.
  • Defined 70% downside threshold for maturity scenarios.
Risk Factors
  • Full downside exposure if stock falls below threshold at maturity.
  • Contingent coupons unpaid if stock price misses barrier dates.
  • Unsecured UBS obligations add credit risk to equity volatility.
  • Illegal secondary market liquidity makes early exit difficult.
Bullish Signals
  • The notes offer the potential for periodic contingent coupons if Blackstone's stock price remains above the coupon barrier on observation dates.
  • An automatic call feature allows for early redemption and return of principal plus accrued coupons if Blackstone's stock performs well and hits the initial level.
  • The structured product provides a defined investment horizon with specific terms set at issuance, including a 70% downside threshold for maturity scenarios.
Risk Factors
  • Investors face full downside equity exposure at maturity if the notes are not called early and the final stock price falls below the downside threshold.
  • Contingent coupons are not guaranteed and will not be paid if Blackstone's stock price fails to meet the coupon barrier on any observation date.
  • All payments are unsecured obligations of UBS AG, meaning investors are exposed to UBS's credit risk in addition to Blackstone's equity volatility.
  • The notes are not listed on any exchange and may have little to no secondary market liquidity, making early exit difficult without potential losses.
Bullish +65

Blackstone (BX) Is Up 7.5% After Deepening Nippon Life Alliance and Funding Anthropic – Has The Bull Case Changed? - simplywall.st

🤝 ¥1.5T commitment with Nippon Life over five years for urban properties.

💰 Co-led US$35B private credit financing for AI firm Anthropic.

🔄 Re-entering talks to acquire C$10.5B H&R REIT property portfolio.

📈 Analysts project $21.5B revenue and $10.5B earnings by 2028.

⚠️ Risks include market volatility, slower asset realizations, and fee pressure.

🤝 Blackstone announced a comprehensive partnership with Nippon Life Insurance Company involving a planned ¥1,500,000 million commitment over five years.

🏢 The Nippon Life alliance includes collaboration on roughly a dozen large urban properties and personnel exchanges to deepen risk management expertise.

💰 Blackstone co-led a massive US$35 billion private credit financing package for AI firm Anthropic, demonstrating its scale in alternative lending.

🔄 Blackstone re-entered talks to acquire H&R REIT's C$10.5 billion property portfolio, highlighting continued activity in real estate transactions.

📈 Analysts project Blackstone revenue of $21.5 billion and earnings of $10.5 billion by 2028, requiring 16.7% yearly growth.

🎯 Optimistic analyst models forecast revenue near $23.0 billion and earnings near $11.9 billion by 2029.

💡 Some fair value estimates suggest the stock could be worth up to 49% more than its current price.

⚠️ Key risks include market volatility, slower asset realizations, and potentially delayed deployment of Blackstone's dry powder.

📉 Fee income may face pressure from redemption trends and choppy fundraising conditions despite new strategic wins.

🧠 The Nippon Life and Anthropic deals reinforce Blackstone's private credit focus but do not eliminate near-term structural risks.

Bullish Signals
  • Secured US$35B financing for AI firm Anthropic.
  • Nippon Life commitment of ¥1.5 trillion over five years.
  • Expanding real estate footprint with dozen urban properties.
  • Analysts view private credit expansion as core earnings catalyst.
  • Projected 2029 revenue $23.0B and earnings $11.9B.
  • Stock potentially undervalued by up to 49%.
Risk Factors
  • Market volatility may pressure Blackstone's fee income despite strategic wins.
  • Dry powder deployment delayed by uneven markets and high debt levels.
  • Uneven share returns create uncertainty about capital attraction capabilities.
  • Choppy fundraising conditions could slow private credit opportunity conversion.
Bullish Signals
  • Blackstone secured a massive US$35 billion private credit financing package for AI firm Anthropic, signaling strong demand from high-growth tech sectors.
  • The partnership with Nippon Life Insurance Company includes a substantial ¥1.5 trillion commitment over five years, providing long-term capital stability.
  • Blackstone is actively expanding its real estate footprint through collaborations on roughly a dozen large urban properties with Nippon Life.
  • Analyst consensus views private credit expansion as a core earnings catalyst for Blackstone, supported by these new strategic deals.
  • Optimistic analyst models project revenue of $23.0 billion and earnings of $11.9 billion by 2029, indicating strong growth potential.
  • Fair value estimates from Simply Wall St suggest the stock could be undervalued by up to 49% based on projected financial performance.
Risk Factors
  • Market volatility and redemption trends could pressure Blackstone's fee income despite recent strategic wins.
  • The deployment of Blackstone's sizeable dry powder may be delayed due to uneven market conditions and high debt levels.
  • Recent share returns have been uneven, creating uncertainty about the firm's ability to attract capital in a challenging environment.
  • Broader fundraising conditions remain choppy, which could impact the speed at which Blackstone converts private credit opportunities into fee revenue.
Bearish -65

New Mexico regulators get recommendation to void PNM-Blackstone stock sale - Santa Fe New Mexican

🚫 Examiners void $400M stock sale due to missing prior approval.

💰 Directive includes unwinding deal and imposing $300,000 fines.

⚖️ Executives' change-of-control defense rejected by hearing examiners.

📉 Companies must withdraw application and file new one if approved.

🛡️ Firms must prove ratepayers remain harmless from reversal costs.

🚫 Hearing examiners recommended voiding a $400 million stock sale from PNM's parent company TXNM Energy to Blackstone due to lack of required prior approval.

💰 The regulatory recommendation includes a directive to unwind the transaction and impose fines totaling $300,000 against both companies.

⚖️ Company executives argued the state law did not apply because the sale did not effect a change in control, but examiners rejected this defense.

📉 If approved, PNM and Blackstone must withdraw their acquisition application and file a new one addressing the unlawful transaction.

🛡️ The ruling requires companies to prove that New Mexico ratepayers will be held harmless from costs related to reversing the stock sale.

🗣️ Advocacy groups praised the decision, stating it sends a clear message that large firms cannot ignore state utility laws.

📅 The Public Regulation Commission is set to vote on the recommendation during a closed-door meeting scheduled for Thursday.

Bullish Signals
  • Regulatory body upheld procedural integrity by rejecting bypass arguments.
  • Advocacy groups view decision as significant victory for rule of law.
  • Ruling establishes precedent for billion-dollar firms to follow state laws.
Risk Factors
  • PNM/Blackstone face $400M void risk and reputational damage.
  • Withdrawal advised, creating takeover deal uncertainty.
  • Combined $300k fine for unapproved transaction completion.
  • Voiding sale may hurt investor views in New Mexico.
  • Must prove ratepayers harmless from reversal costs.
Bullish Signals
  • The regulatory body has upheld the principle of procedural integrity by rejecting arguments that allowed companies to bypass explicit state law requirements.
  • Advocacy groups and consumer representatives view the decision as a significant victory for the rule of law in the utility sector.
  • The ruling establishes a clear precedent that billion-dollar Wall Street firms must adhere to state regulations without seeking special exemptions.
Risk Factors
  • PNM and Blackstone face a recommendation to void a $400 million stock transaction, potentially causing significant financial loss and reputational damage.
  • The companies are advised to withdraw their acquisition application, creating uncertainty about the future of the proposed takeover deal.
  • Both entities face a combined fine of $300,000 for completing the transaction without necessary regulatory approval.
  • Executives warned that voiding the sale could negatively impact investor views and signal a challenging investment environment in New Mexico.
  • The companies must now prove to regulators that ratepayers will be held harmless from any costs associated with reversing the deal.
Very Bullish +80

Blackstone, CPPIB-backed AirTrunk to invest over $30 bn in India's data centres by 2030

📈 AirTrunk plans $30B India data centre investment by 2030.

🏗️ Pipeline includes 600MW projects across Mumbai, Chennai, and Hyderabad.

🤝 CEO secured meetings to accelerate power, water, and approvals.

👥 Projects will create tens of thousands of local jobs.

🌱 Sustainable financing supports scalable, lower-cost hyperscale development.

📈 AirTrunk, backed by Blackstone and CPPIB, plans to invest over $30 billion in India's data centre sector by 2030.

🌍 This investment is part of a broader strategy to position India as a global hub for AI and cloud computing.

🏗️ The project pipeline spans multiple states and aims to generate significant jobs and economic growth.

💰 Blackstone and CPPIB acquired AirTrunk in 2024, valuing the company at over Australian $24 billion.

🔋 AirTrunk already has a development pipeline of 600MW across Mumbai, Chennai, and Hyderabad following its acquisition of Lumina CloudInfra.

🤝 CEO Robin Khuda met with government representatives in Maharashtra and Andhra Pradesh to discuss infrastructure acceleration.

⚡ Key discussion points included power access, clean energy, water availability, talent pipelines, and faster approvals.

📉 AirTrunk's platform offers scalable data centre solutions at lower build and operating costs than the market average.

🌱 The company utilizes a sustainable financing platform to fund hyperscale data centre development across regions.

👥 Each major project is expected to support tens of thousands of local jobs in development, construction, and operation.

🔗 Investment will drive long-term productivity through localization of supply chain operations and engagement with local businesses.

🏛️ India's top-down approach to AI, including government-led initiatives and renewable energy availability, attracted the investment.

📰 The announcement marks one of AirTrunk's most significant long-term market commitments in its global growth strategy.

Bullish Signals
  • AirTrunk invests $30B+ in India data centres by 2030.
  • Project spans multiple states to boost AI, cloud, and jobs.
  • Company has sustainable financing for 600MW Mumbai/Chennai/Hyderabad pipeline.
  • CEO Robin Khuda doubles down on India market commitment.
  • Platform offers scalable solutions with lower build and operating costs.
Risk Factors
  • $30B India pipeline hinges on power, water, talent.
  • Power/clean energy/water/talent access required for 2030 goals.
Bullish Signals
  • AirTrunk, backed by Blackstone and CPPIB, plans to invest over $30 billion in India's data centres by 2030, marking one of its most significant long-term market commitments.
  • The investment pipeline spans multiple states and supports India's push to become a global hub for AI and cloud investment while generating jobs and economic growth.
  • AirTrunk is well-capitalized with a sustainable financing platform to fund the development of hyperscale data centres across regions, including its existing 600MW pipeline in Mumbai, Chennai, and Hyderabad following the Lumina CloudInfra acquisition.
  • CEO Robin Khuda stated they were bullish on India before entering the market and are now looking to double down on that commitment after discussions with government leaders.
  • The company's growing data centre platform delivers scalable solutions at significantly lower build and operating costs than the market, enhancing competitiveness.
  • AirTrunk is investing in 5GW of new data centre capacity which underpins significant local economic opportunities, supporting tens of thousands of jobs in development, construction, and operation.
  • The investment attracts cloud, AI, and technology investment that drives long-term productivity and economic growth through the localization of supply chain operations and engagement with local businesses.
Risk Factors
  • AirTrunk's $30 billion investment pipeline in India by 2030 is contingent on securing power access, clean energy, water availability, and talent pipelines, which are explicitly listed as key discussion topics with government representatives.
Somewhat Bearish -25

Blackstone restricts flagship fund withdrawals as private asset fears reemerge

📉 Blackstone capped BCRED withdrawals at 5% after Q2 redemptions hit 10%.

💰 Record Q1 outflows were covered by employee capital despite $1B inflows.

🗣️ Executives warn of spreading liquidity pressures across private credit and equity sectors.

📉 Blackstone restricted withdrawals from its flagship BCRED fund after redemption requests spiked to 10% in Q2.

💰 The firm capped investor withdrawals at 5% of shares for the $79 billion nontraded business development company.

⚠️ This move follows a broader sell-off among private markets giants, including Partners Group curbing redemptions in European vehicles.

📊 BCRED previously saw record redemption requests of 7.9% ($3.8 billion) in Q1, which Blackstone fully fulfilled using employee capital.

🔄 The fund recorded a net capital outflow after covering withdrawals despite drawing $1 billion in inflows during Q1.

🗣️ Jon Gray, Blackstone's COO and President, stated that withdrawal caps are a feature designed to protect long-term investors.

📈 Shares of Blackstone rose more than 5% on Thursday following the announcement of the withdrawal restrictions.

⚠️ Partners Group warned that client withdrawals are spreading from private credit into private equity sectors.

🔮 Daniel Ivascyn of Pimco warned that the industry is in the midst of a sustained default or loss cycle.

📅 The news emerged on Thursday, June 4, 2026, amid renewed fears over liquidity pressures in private markets.

Bullish Signals
  • Blackstone shares rose over 5% Thursday.
  • BCRED fulfilled 100% of Q1 redemptions.
  • Fund drew $1B inflows in Q1.
  • BCRED demonstrates transparency with redemption updates.
  • Liquidity caps protect long-term investors.
Risk Factors
  • BCRED fund redemption requests hit 10% in Q2.
  • Blackstone capped withdrawals at 5% due to strain.
  • $3.8B outflow exceeded $1B inflows for the fund.
  • Employee capital used to meet all Q1 withdrawals.
  • Pimco warns of sustained credit industry default cycle.
Bullish Signals
  • Shares in Blackstone were up more than 5% in late-morning trading Thursday, recovering from the previous day's sell-off.
  • Blackstone fulfilled 100% of client redemption requests in Q1 by raising its quarterly cap and using employee capital to cover the remaining amount.
  • The fund drew inflows of about $1 billion during the first quarter despite subsequent net outflows.
  • BCRED is one of the first major semi-liquid private credit vehicles providing updates on investor redemption requests, demonstrating transparency.
  • Blackstone's Chief Operating Officer Jon Gray stated that liquidity caps are a 'feature, not a bug,' designed to protect long-term investors.
Risk Factors
  • Redemption requests for the BCRED fund reached approximately 10% in Q2, forcing Blackstone to cap withdrawals at 5%.
  • The fund recorded a net capital outflow after covering $3.8 billion in Q1 redemption requests despite drawing about $1 billion in inflows.
  • Blackstone had to utilize employee capital to fulfill 100% of the Q1 withdrawal requests, indicating significant liquidity strain.
  • Pimco's chief investment officer warned of a sustained default or loss cycle in the credit industry, suggesting deeper underlying issues.
  • Partners Group warned that client withdrawals are spreading from private credit into private equity sectors, signaling broader market contagion.
Somewhat Bullish +50

Blackstone Private Credit Fund Caps Withdrawals As Redemption Requests Jump

📉 Blackstone capped withdrawals at 5% after redemption requests hit 10%.

💸 Wealthy investors withdrew more than they invested in non-traded funds for the first time.

🤝 Blackstone and employees pooled resources to meet initial redemption demands before limits applied.

📈 Shares rose 8% as peers also restricted redemptions from private equity funds.

🛡️ The fund prioritizes long-term returns over liquidity, maintaining a strong capital position.

📉 Blackstone capped withdrawals at 5% for its $79 billion flagship private credit fund after redemption requests jumped to 10% in the second quarter.

💸 Wealthy investors pulled out more money from non-traded funds like BCRED than they put in, marking a first for this asset class.

🤝 Blackstone and some employees pooled resources to help meet all initial redemption requests before imposing the new limit.

📊 Analysts noted that while 10% redemptions were higher than feared, there are concerns about continued investor demand due to a slowdown in gross sales.

📈 Blackstone shares rose 8% on Thursday after peers like Partners Group also limited redemptions from their private equity funds.

🛡️ The fund's structure prioritizes long-term outperformance over immediate liquidity, exchanging access to capital for better returns.

💰 BCRED remains well capitalized with loan repayments and inflows currently outpacing share repurchases.

📉 Net outflows for the quarter were about 3% due to fewer new buyers entering the fund compared to withdrawals.

🏗️ Deal activity is increasing as debt yields higher returns compared to the first quarter, according to Blackstone's assessment.

🔜 Redemption windows for major U.S. non-traded private credit funds are set to expire throughout June.

📉 Other firms like Blue Owl have seen renewed appetite from wealthy investors in asset classes such as real estate while private credit stays out of favor.

📈 Class I shares of BCRED have delivered a 9.3% annualized total return since inception, representing a 50% premium to leveraged loans.

Bullish Signals
  • Blackstone shares rose 8% after announcement.
  • Fund remains well capitalized with strong inflows.
  • BCRED Class I shares delivered 9.3% annualized return.
  • Gross fundraising accelerated across private wealth products.
  • Deal activity increases as debt yields rise.
Risk Factors
  • Redemptions surged to 10%, forcing Blackstone to cap withdrawals at 5%.
  • Net outflows hit 3% amid a historic slowdown in new capital purchases.
  • Analysts warn of prolonged investor demand issues for non-traded private credit assets.
  • Blackstone reverted redemption thresholds after pooling employee resources to pay prior requests.
  • Major U.S. fund windows expire in June, creating uncertainty from peer results.
Bullish Signals
  • Blackstone shares rose 8% following the announcement, with many peers following suit after initial concerns.
  • The fund remains well capitalized, with loan repayments combined with inflows outpacing share repurchases.
  • BCRED's Class I shares have delivered a 9.3% annualized total return since inception, representing a 50% premium to leveraged loans.
  • Blackstone reported an acceleration in gross fundraising across its other private wealth products.
  • Deal activity is increasing with debt paying higher yields compared to the first quarter as markets stabilize.
  • The fund's structure allows investors to exchange some liquidity for long-term outperformance, preserving capital to deploy in attractive market environments.
Risk Factors
  • Redemption requests surged to 10% in the second quarter, up from 7.9% previously, forcing Blackstone to cap withdrawals at the customary 5% threshold.
  • The fund experienced net outflows of about 3% due to a significant slowdown in new capital purchases, marking the first time inflows were lower than outflows for this asset class in the current year.
  • Analysts flagged concerns about continued investor demand for non-traded private credit assets, noting that the big slowdown in gross sales is a larger and more prolonged issue for both BCRED and the industry.
  • Blackstone had to revert from a previously raised redemption threshold back to standard limits after pooling resources with employees to pay back all requested funds in the prior quarter.
  • Redemption windows across major U.S. non-traded private credit funds are set to expire throughout June, creating uncertainty as market participants watch results from peers like Partners Group which also reported higher withdrawal requests.
Bearish -50

Blackstone, Partners Group cap withdrawals as redemptions rise amid private markets strain

📉 Major firms like Partners and Blackstone capped withdrawals due to surging redemption requests exceeding limits.

📊 Private credit funds face volatility with some seeing redemptions jump from 7% to over 17%.

🌍 Market turmoil caused asset manager shares to fall globally before partial recoveries in the U.S.

💬 Experts warn evergreen structures struggle under pressure, favoring closed-ended models instead.

📈 Partners Group expects strong $26B–$32B new demand for 2026 despite current liquidity issues.

📉 Partners Group flagged increased withdrawal requests from its funds while Blackstone capped withdrawals at its flagship private credit fund.

💸 Repurchase requests at Partners' $16 billion Delaware-based fund reached 6% of assets, exceeding the 5% quarterly limit and triggering a cap on withdrawals.

🏦 The middle-market alternative asset manager overseeing $185 billion is facing industry-wide volatility across open-ended evergreen funds starting with private credit.

📊 Blackstone capped withdrawals at its flagship private credit fund as redemption requests jumped to 10% in the second quarter compared to 7.9% previously.

🚫 Unlike last quarter, Blackstone and employees did not invest to meet all requested redemptions, limiting withdrawals to the customary 5% limit for these vehicles.

📉 Partners Group limited withdrawals from its $8.6 billion private equity fund after redemption requests reached 9.8% of assets held in the Luxembourg-based SICAV.

🔮 Three other mature evergreen funds totaling $9.7 billion are estimated to see redemptions between 3.5% and 5%, according to Partners Group.

📈 Partners Group shares recovered somewhat after falling 16% to a six-year low on Wednesday following news of the redemption cap.

🌍 The slump in Partners Group shares caused peer asset managers in Europe including EQT, CVC Capital Partners, and Bridgepoint Group to see their shares fall.

🇺🇸 In the U.S., shares of major asset managers Blackstone, KKR, TPG, and Ares Management also fell before Blackstone's stock rose 7% on Thursday.

💬 Virinchi Narayan of Three Pins Capital noted that evergreen structures are difficult to fulfill and closed-ended structures remain the best approach for these funds.

📉 Cliffwater reported withdrawal requests at its flagship $31.3 billion private credit fund rose to 17% in the second quarter from 14% in the first quarter.

🔍 Investors are scrutinizing valuations, lending standards, and how software companies can handle AI challenges within private credit funds run by big asset managers.

📅 Redemption windows at key U.S. non-traded private credit funds for the second quarter began closing last Friday with market participants monitoring withdrawal rates closely.

🤝 Partners Group expects gross new client demand of $26 billion to $32 billion for 2026 supported by a large pipeline of fundraising opportunities across mandates.

Bullish Signals
  • Blackstone shares rose 7% after capping private credit withdrawals.
  • Partners Group expects $26B-$32B new demand for 2026.
  • Strong demand helped Partners Group recover from a 16% drop.
  • Blackstone trades liquidity for long-term outperformance in its fund.
Risk Factors
  • Blackstone capped withdrawals after redemption requests jumped to 10%.
  • Partners Group capped $16B fund withdrawals at 6%, exceeding the 5% limit.
  • Cliffwater saw withdrawal requests rise from 14% to 17% at its $31.3B fund.
  • Partners Group shares plunged 16% after capping $8.6B fund withdrawals.
  • Evergreen structures may fail as funds were designed for closed-ended models.
Bullish Signals
  • Blackstone shares rose 7% on Thursday following the announcement that it capped withdrawals at its flagship private credit fund.
  • Partners Group expects gross new client demand between $26 billion and $32 billion for 2026, supported by a large pipeline of fundraising opportunities.
  • The confirmation of strong future demand helped Partners Group shares recover after falling 16% to a six-year low on Wednesday.
  • Blackstone stated that its fund structure is a fundamental feature where investors exchange some liquidity at times for long-term outperformance.
Risk Factors
  • Blackstone capped withdrawals at its flagship private credit fund after redemption requests jumped to 10% in the second quarter compared to 7.9% previously, limiting access to the customary 5% threshold.
  • Partners Group reported that repurchase requests at its $16 billion Delaware-based fund reached 6% of assets held, exceeding its standard 5% quarterly limit, prompting a cap on withdrawals.
  • Cliffwater also reported rising withdrawal requests at its $31.3 billion fund, increasing from 14% in the first quarter to 17% in the second.
  • Partners Group noted that while it capped withdrawals from its $8.6 billion private equity fund due to a 9.8% redemption request, shares plunged 16% to a six-year low before recovering somewhat.
  • Industry experts warn that the shift toward evergreen structures driven by investor demand for liquidity may be difficult to sustain under current market conditions, as these funds were originally designed with closed-ended structures in mind.
Neutral 0

Stocks making the biggest moves midday: Five Below, Broadcom, Blackstone, UnitedHealth & more

🧬 Alnylam shares rose 4% following a $2 billion AI partnership with Inceptive Nucleics.

💼 Blackstone jumped 8% as it limits Private Credit fund withdrawals, lifting peers Ares and KKR.

📉 Broadcom missed revenue expectations, causing semiconductor stocks like Micron and Intel to slide.

🛍️ Five Below fell 13% despite beating revenue forecasts, while PVH plunged 20% on guidance.

❤️‍🩹 UnitedHealth and Medtronic advanced after buy upgrades citing improving cost trends and setups.

🧬 Alnylam Pharmaceuticals shares rose 4% after announcing a strategic AI collaboration with Inceptive Nucleics valued at up to $2 billion.

💼 Blackstone stock jumped 8% as investors reacted positively to news that the firm is limiting withdrawals from its Private Credit fund.

🤝 Fellow asset managers Ares Management and KKR each saw shares gain 6% in sympathy with Blackstone's move.

🏥 Humana shares rose more than 6% after Morgan Stanley raised its price target to $249, though the rating remains underweight.

💻 Broadcom shares tumbled nearly 15% after reporting fiscal second-quarter revenue of $22.19 billion, missing analyst expectations of $22.27 billion.

🤖 Despite the miss, Broadcom CEO Hock Tan reiterated that fiscal year 2027 AI chip revenue guidance remains "in excess of $100 billion."

📉 Semiconductor stocks broadly slid following Broadcom's results, with Micron down almost 7%, Intel down 2%, and AMD down 4%.

🛍️ Five Below shares fell 13% despite providing a better-than-expected outlook for second-quarter revenue and same-store sales growth.

🐾 Petco stock dropped roughly 8% after its current-quarter EBITDA forecast came in shy of Wall Street expectations.

🛡️ CrowdStrike's stock lost 6% on lackluster second-quarter guidance, causing shares of Palo Alto Networks to trade lower in sympathy.

👔 PVH stock plunged 20% after reiterating full-year earnings guidance despite posting a first-quarter earnings beat.

🏥 UnitedHealth shares climbed 5% following an upgrade from Bank of America to buy based on improving medical cost trends.

❤️‍🩹 Medtronic's stock advanced 4% after BTIG upgraded shares to buy, citing an attractive top-line setup and discount to peers.

Bullish Signals
  • Alnylam shares up 4% on $2B AI deal with Inceptive Nucleics.
  • Blackstone stock jumped 8% snapping three-day losses after redemption news.
  • Ares Management and KKR shares gained 6% in sympathy with Blackstone.
  • Humana rose over 6% as Morgan Stanley raised target to $249.
  • Broadcom CEO Tan reaffirmed FY2027 AI chip revenue guidance above $100B.
  • Five Below beat outlook with same-store sales expected up 7-9%.
  • UnitedHealth climbed 5% after Bank of America upgraded to buy.
  • Medtronic advanced 4% as BTIG upgraded shares citing attractive setup.
Risk Factors
  • Shares rose 8% despite private credit fund withdrawal limits.
  • Redemption requests spiked before investor sentiment improved.
Bullish Signals
  • Alnylam Pharmaceuticals shares advanced 4% after announcing a strategic artificial intelligence collaboration with Inceptive Nucleics valued at up to $2 billion.
  • Blackstone shares jumped 8% as the stock is now on track to snap a three-day string of losses following investor redemption news.
  • Fellow asset managers Ares Management and KKR each saw shares gain 6% in sympathy with Blackstone's positive move.
  • Humana shares rose more than 6% after Morgan Stanley raised its price target to $249 per share, suggesting roughly 24% upside from Wednesday's close.
  • Broadcom CEO Hock Tan reiterated the company's fiscal year 2027 revenue guidance for AI chips to be in excess of $100 billion.
  • Five Below provided a better-than-expected outlook with same-store sales expected to grow 7% to 9%, versus a 4.4% consensus.
  • UnitedHealth shares climbed 5% following an upgrade at Bank of America to buy from neutral due to improving medical cost trends.
  • Medtronic's stock advanced 4% after BTIG upgraded shares to buy from neutral, citing an attractive top-line setup and a discount to peers.
Risk Factors
  • Blackstone shares jumped 8% after investors appeared to shake off news regarding withdrawal limits on the Blackstone Private Credit fund following a pickup in redemption requests.
Bullish +75

Japan's Nippon Life to Invest About $9.4 Billion in Blackstone's Credit Strategies

📈 Nippon Life invests $9.4B in Blackstone's credit strategies over five years.

🤝 MOU signed to form a major Asia-Pacific strategic partnership.

🏢 Collaboration targets ~12 properties including large-scale urban assets.

🌏 Deal expands Nippon Life's alternative investments amid Japan's rate shift.

📈 Nippon Life Insurance plans to invest approximately $9.4 billion in Blackstone's credit strategies.

💰 The commitment is equivalent to about 1.5 trillion yen and will be made over the next five years.

🤝 A memorandum of understanding was signed to establish a new strategic partnership between the two firms.

🏢 Nippon Life intends to leverage Blackstone's capabilities to enhance the value of its real-estate holdings.

🏙️ The companies plan to collaborate on approximately a dozen properties, including large-scale urban assets.

📉 Nippon Life is expanding alternative investments like private credit due to Japan's shift away from low-interest rates and deflation.

🌏 Blackstone President Jon Gray described the deal as one of the most significant multiasset private-credit partnerships in the Asia-Pacific region.

🛠️ Blackstone will provide investment management services specifically in the private-credit and real-estate sectors.

Bullish Signals
  • Nippon Life invests $9.4B in Blackstone's credit strategies.
  • Five-year partnership ensures long-term stability for both entities.
  • Collaboration covers a dozen properties including urban assets.
  • Deal is a major Asia-Pacific private-credit partnership.
  • Nippon Life secures opportunities amid shifting economic conditions.
Risk Factors
  • No negative aspects or risks identified.
  • No declining metrics or threats mentioned.
Bullish Signals
  • Nippon Life Insurance plans to invest approximately $9.4 billion in Blackstone's credit strategies, representing a major expansion of its allocation to investment-grade private credit and structured credit.
  • The partnership is expected to last for the next five years, providing long-term stability and growth potential for both entities.
  • Nippon Life will leverage Blackstone's asset-management capabilities to boost the value of its real-estate holdings through a collaboration on about a dozen properties, including large-scale urban assets.
  • Blackstone President Jon Gray described the partnership as one of the most significant multiasset private-credit partnerships in the Asia-Pacific region, highlighting its strategic importance.
  • The deal allows Nippon Life to secure high-quality investment opportunities as it expands alternative investments in response to shifting economic conditions away from low-interest rates and deflation.
Risk Factors
  • The article contains no negative aspects or risks; it exclusively reports on a $9.4 billion investment partnership between Nippon Life and Blackstone.
  • There are no declining metrics, competitive threats, regulatory concerns, or downside catalysts mentioned in the provided text.
Bearish -50

Blackstone to sell Seattle office building for ~54% below purchase price - report

🏢 Blackstone sells Seattle's U.S. Bank Center to Spear Street Capital for $280 million.

💸 Sale price is 54% below the original 2019 purchase cost of $612 million.

📅 Bloomberg reported the deal on May 29, 2026, signaling a portfolio shift.

🏢 Blackstone Inc. (BX) is selling the U.S. Bank Center in Seattle to Spear Street Capital for approximately $280 million.

💸 The sale price represents a significant loss, being about 54% below the building's original purchase price of $612 million in 2019.

📅 The deal was reported by Bloomberg News on May 29, 2026, according to sources with knowledge of the transaction.

🏙️ Spear Street Capital is an office landlord acquiring the property from Blackstone.

📉 This transaction highlights a potential shift in Blackstone's real estate portfolio strategy or market conditions affecting commercial properties.

📰 The news was published on Seeking Alpha by Mary Christine Joy.

Bullish Signals
  • Blackstone sold Seattle's U.S. Bank Center to Spear Street Capital.
  • Deal unlocks $280M capital for Blackstone's other investments.
  • Spear Street acquisition shows institutional demand for office assets.
  • Sale highlights Blackstone's active portfolio management and market agility.
Risk Factors
  • Blackstone sells Seattle center at 54% loss vs $612M cost.
  • Steep discount signals weak office demand or unresolved asset issues.
Bullish Signals
  • Blackstone (BX) has successfully identified a buyer, Spear Street Capital, for the U.S. Bank Center in Seattle, facilitating a strategic exit from the asset.
  • The transaction allows Blackstone to unlock approximately $280M in capital tied up in the property, providing liquidity for other investment opportunities.
  • Spear Street Capital's acquisition of the building demonstrates continued institutional demand for office assets, even at a discount to Blackstone's original cost.
  • This sale reflects Blackstone's active portfolio management and ability to adjust its real estate holdings in response to changing market conditions.
Risk Factors
  • Blackstone (BX) is selling the U.S. Bank Center in Seattle for approximately $280M, which represents a significant loss of about 54% from its original purchase price of $612M in 2019.
  • The steep discount on the sale suggests deteriorating demand for office real estate or structural issues with the asset that Blackstone could not resolve.
Somewhat Bullish +50

Blackstone Credit & Insurance Announces Extension of Reinvestment Period Ahead of May 31, 2027, Scheduled Dissolution Date for Blackstone Senior Floating Rate 2027 Term Fund

📅 Blackstone Senior Floating Rate 2027 Term Fund extends reinvestment period to May 31, 2026.

💼 Extension allows continued income generation via new investments until liquidation plan adoption.

⚠️ Early liquidation and increased risk would occur without this extension.

📅 Blackstone Senior Floating Rate 2027 Term Fund (NYSE: BSL) announced an extension of its reinvestment period on May 29, 2026.

🏛️ The Fund's Board of Trustees approved the extension following a recommendation from investment adviser Blackstone Liquid Credit Strategies LLC.

📉 The original reinvestment period was set to expire on May 31, 2026, which is one year before the scheduled dissolution date of May 31, 2027.

💼 The extension allows the Fund to continue reinvesting proceeds from maturities, prepayments, and sales of investments until a plan of liquidation becomes effective.

🎯 This move aims to enable the Fund to generate income through new investments consistent with its investment objectives.

⚠️ Without the extension, the Fund would have been unable to reinvest proceeds after May 31, 2026, potentially forcing early liquidation and increasing portfolio risk.

📈 Management believes the extension benefits shareholders by supporting continued income generation and risk management until liquidation begins.

🗓️ The Fund is expected to complete an orderly liquidation by the May 31, 2027 dissolution date following the adoption of a liquidation plan.

⚖️ There is no assurance that adverse market conditions will not arise during the extended period, which could impact the ability to liquidate assets.

📉 Shareholders are not expected to receive liquidating distributions until after the effective date of a Board-adopted plan of liquidation.

🔗 Additional risk disclosures and information about the Fund are available on Blackstone's website at www.blackstone.com/bxci-closed-end-funds.

📞 Investors can contact the Fund directly at 1 (877) 299-91588 for further inquiries regarding the extension or fund status.

Bullish Signals
  • Board approved reinvestment period extension until May 31, 2027.
  • Extension avoids premature liquidation after May 31, 2026.
  • Ensures orderly liquidation and continued risk management.
  • Blackstone Credit & Insurance leads global credit investing.
  • Fund targets attractive returns for all investors.
Risk Factors
  • Fund dissolves May 31, 2027, limiting long-term horizons.
  • Inherent instability forces early liquidation without extension.
  • Adverse markets may disrupt orderly liquidation completion.
  • Capital return delayed until liquidation plan adoption.
  • Uncertain payout timing relies on Board action.
Bullish Signals
  • The Board approved an extension of the reinvestment period, allowing the Fund to continue generating income through new investments until liquidation.
  • This extension prevents premature liquidation of holdings after May 31, 2026, thereby avoiding a higher concentration of risk in the loan portfolio.
  • The Adviser believes the extension benefits shareholders by ensuring orderly liquidation and continued risk management until the dissolution date on May 31, 2027.
  • Blackstone Credit & Insurance remains one of the world's leading credit investors with a diverse portfolio spanning private investment grade, asset-based lending, high yield, infrastructure debt, and direct lending.
  • The Fund seeks to generate attractive risk-adjusted returns for both institutional and individual investors by providing capital to strengthen and grow businesses.
Risk Factors
  • The Fund is scheduled to dissolve on May 31, 2027, creating a hard deadline for liquidation that limits long-term investment horizons.
  • Without the extension, the Fund would have been forced to liquidate holdings well in advance of the dissolution date, indicating inherent instability in its asset lifecycle.
  • There is no assurance that the Fund will not face adverse market conditions during the extended reinvestment period that could impact its ability to complete an orderly liquidation.
  • Shareholders are not expected to begin receiving liquidating distributions until after a plan of liquidation is adopted, delaying capital return for investors.
  • The extension relies on the Board adopting a plan of liquidation at an unspecified future date, introducing uncertainty regarding the timing of shareholder payouts.
Very Bullish +85

Apogee Therapeutics Announces $1.3 Billion Strategic Financing Collaboration with Blackstone Life Sciences to Advance Phase 3 Development and Commercialization of Zumilokibart

📈 Apogee secures $1.3B non-dilutive capital via Blackstone Life Sciences collaboration.

💰 Funding combines synthetic royalty options with senior corporate debt tranches.

🚀 Partnership enables financial self-sustainability and advances zumilokibart for atopic dermatitis.

🛡️ Deal includes FDA-dependent funding triggers and buyback change-of-control provisions.

📣 Webcast details transaction terms and APEX Phase 2 Part B results today.

📈 Apogee Therapeutics enters a strategic financing collaboration with Blackstone Life Sciences for up to $1.3 billion in flexible, non-dilutive capital.

💰 The transaction includes up to $800 million of synthetic royalty funding and up to $500 million in senior corporate debt.

🚀 Combined with existing cash reserves of $1.3 billion, Apogee now projects a self-sustainable financial profile without needing future equity financing.

🩺 CEO Michael Henderson described the partnership as a major milestone for advancing zumilokibart as a first-line therapy for moderate-to-severe atopic dermatitis.

📊 Synthetic royalty funding includes tiered royalties on worldwide annual sales, decreasing based on performance with no royalties above $8 billion in global sales.

💸 The initial preapproval funding is divided into three tranches: $100 million at signing, $100 million upon Phase 3 enrollment, and $200 million after positive Phase 3 data.

🔑 Post-FDA approval allows for an additional $400 million in funding, with $150 million available at Apogee's option to pursue commercialization.

🛡️ The agreement includes specific provisions regarding change of control, offering the option to buy back a significant portion of the royalty.

📣 Apogee will host a webcast today at 8:00 a.m. Eastern Time to discuss the transaction and announce APEX Phase 2 Part B results.

🏢 Goldman Sachs served as exclusive financial advisor while Latham & Watkins LLP provided legal counsel to Apogee Therapeutics.

🔬 Blackstone Life Sciences notes this collaboration exemplifies their strategy to provide leading biotechnology companies with non-dilutive financing at scale.

🌐 Kiran Reddy of Blackstone cited this as the largest royalty financing for a pre-Phase 3 program, reflecting conviction in zumilokibart's potential.

💊 Zumilokibart is Apogee's most advanced program, initially developed for atopic dermatitis with expansion into asthma and eosinophilic esophagitis.

🔍 The company operates with four validated targets in its portfolio, seeking best-in-class efficacy through monotherapies and combinations of novel antibodies.

Bullish Signals
  • Up to $1.3B secured from Blackstone Life Sciences.
  • $800M synthetic royalty component with low-to-mid single-digit royalties.
  • $100M first tranche funding at signing.
  • Up to $500M senior corporate debt available.
Risk Factors
  • $1.3B financing includes $800M synthetic royalty liability contingent on drug sales.
  • Royalty threshold of $8B unrealistically targets market cannibalization causing financial strain.
  • $400M preapproval funding contingent on positive Phase 3 and FDA approval.
  • Additional $400M post-approval funding is discretionary with no guaranteed long-term liquidity.
  • $500M debt available only upon mutual consent introduces potential refinancing risk.
Bullish Signals
  • Apogee Therapeutics secured up to $1.3 billion in flexible, non-dilutive capital from Blackstone Life Sciences, strengthening its financial position for Phase 3 development and commercialization.
  • The company's cash runway is effectively removed, with combined current cash and new financing ($1.3 billion each) enabling a self-sustainable financial profile without the need for future equity dilution.
  • Apogee's CEO Michael Henderson highlighted that the partnership positions zumilokibart as the next meaningful first-line therapy for moderate-to-severe atopic dermatitis, driven by positive Apex Part B data.
  • The synthetic royalty component of up to $800 million has low-to-mid single-digit tiered royalties with no royalties on global annual sales exceeding $8 billion, offering attractive cost of capital.
  • First tranche funding includes $100 million at signing, $100 million upon Phase 3 enrollment completion, and $200 million upon positive Phase 3 data, with an additional $400 million available post-FDA approval.
  • Up to $500 million of senior corporate debt is available at mutual consent, further diversifying the funding structure for the late-stage program.
  • Blackstone Life Sciences termed this the largest royalty financing for a pre-Phase 3 program to date, signaling strong investor confidence in zumilokibart's potential as a differentiated multi-indication product.
  • Apogee is targeting the largest and least penetrated I&I market (atopic dermatitis) with four validated targets in its portfolio, aiming for best-in-class efficacy and dosing.
Risk Factors
  • The $1.3 billion financing package includes up to $800 million in synthetic royalty obligations tied to worldwide annual sales of zumilokibart, creating significant contingent liability if the drug fails to meet high sales thresholds or loses patent exclusivity.
  • Royalty payments are tiered at low-to-mid single digits but decrease with higher sales; however, the $8 billion sales threshold for zero royalties imposes an unrealistic target that could trigger financial strain if achieved via market cannibalization of existing therapies.
  • The first $400 million preapproval funding is contingent on positive Phase 3 data and FDA approval, meaning Apogee must succeed in demonstrating clinical efficacy to access the majority of promised capital.
  • Additional post-approval funding of up to $400 million is discretionary ($150 million at company option), indicating a lack of guaranteed long-term liquidity beyond the initial tranche milestones.
  • The inclusion of up to $500 million in senior corporate debt available only upon mutual consent introduces potential refinancing risk if market conditions deteriorate or Apogee's leverage capacity weakens before approval.
  • Blackstone retaining significant financial interest via royalties may incentivize them to influence development timelines or pricing strategies that could prioritize cost containment over maximizing patient access and long-term revenue potential.
Slightly Bullish +25

Blackstone seasoning recalled after ingredient linked to possible salmonella contamination

⚠️ Blackstone recalls Parmesan Ranch seasoning due to potential salmonella from milk powder.

🏷️ Affected 7.3-ounce lots include numbers 2025-43282, 2025-46172, and 2026-54751.

🛒 Sellable through Walmart stores and the Blackstone Products website directly.

🧪 Customers should stop using product immediately and dispose of it safely.

📞 Call 1-888-879-4610 for replacements or to confirm if you have recalled items.

📦 Blackstone Products is voluntarily recalling select lots of its Parmesan Ranch seasoning sold nationwide through Walmart.

⚠️ The recall stems from a milk powder ingredient linked to possible salmonella contamination flagged by supplier California Dairies, Inc.

❌ No illnesses have been reported as of now following the discovery of the potential contamination risk.

🧪 Salmonella infections can cause severe symptoms including fever, diarrhea, and vomiting, particularly in vulnerable populations.

🏷️ The recall affects 7.3-ounce containers with specific lot numbers: 2025-43282, 2025-46172, and 2026-54751.

📅 Best-by dates for the affected products include July 2, August 5, and August 12, 2027.

🛒 The product was sold both in Walmart stores and directly through Blackstone Products' website.

💬 Customers are advised to dispose of any recalled seasoning immediately and not to consume it.

📞 Interested customers can contact Blackstone Products at 1-888-879-4610 between 8 a.m. and 5 p.m. EST for replacements or questions.

Bullish Signals
  • Proactive recall ensures consumer safety following potential contamination.
  • No illnesses reported to date from affected products.
  • Walmart and Blackstone cooperate on transparent supply chain protocols.
  • Call 1-888-879-4610 for replacements and assistance.
  • Company commits to protecting vulnerable populations.
Risk Factors
  • Salmonella contamination linked to Blackstone Parmesan Ranch seasoning.
  • No illnesses reported yet, but serious or fatal infection risks remain.
  • Affected lot numbers 2025-43282, 2025-46172, and 2026-54751 must be disposed.
  • Product carries pathogen risk before best-by dates ranging from 07/02/2027 to 08/12/2027.
Bullish Signals
  • Blackstone Products has voluntarily recalled select lots of Parmesan Ranch seasoning to ensure consumer safety following a potential contamination issue with an ingredient.
  • No illnesses have been reported to date, indicating that no consumers have yet fallen ill from consuming the affected products.
  • The recall is being handled cooperatively by Blackstone Products and Walmart, demonstrating effective supply chain transparency and communication protocols.
  • Consumers seeking replacement products can contact Blackstone directly at 1-888-879-4610 for assistance and exchanges.
  • This proactive measure highlights the company's commitment to food safety standards and protecting vulnerable populations such as children and older adults.
Risk Factors
  • A nationwide recall of select 7.3-ounce containers of Blackstone Parmesan Ranch seasoning is underway after the ingredient was linked to possible salmonella contamination.
  • The recall stems from a separate issue involving dry milk powder supplier California Dairies, Inc., which raised concerns about contamination in lots supplied to third-party manufacturers.
  • While no illnesses have been reported yet, salmonella infections can cause serious or sometimes fatal symptoms including fever, diarrhea, nausea, vomiting, and abdominal pain.
  • The affected product lots (lot numbers 2025-43282, 2025-46172, and 2026-54751) are specifically targeted for disposal due to the potential health risks associated with the contaminated ingredient.
  • Consumers face a risk of ingesting pathogen-laden seasoning if they do not properly dispose of the recalled product before its best-by dates ranging from 07/02/2027 to 08/12/2027.